Evidence map›Paper›PMID 23427793›Full record

ReviewCritical reviews in clinical laboratory sciences

Common variants of the vitamin D binding protein gene and adverse health outcomes.

Suneil Malik, Lei Fu, David James Juras, Mohamed Karmali, Betty Y L Wong, Agnes Gozdzik, David E C Cole

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Critical reviews in clinical laboratory sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07673718 (α-N-acetylgalactosaminidase in Acute Exacerbation and Remission Stages of Schizoaffective Disorder), which is not on this map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07673718 completednot on this map

α-N-acetylgalactosaminidase in Acute Exacerbation and Remission Stages of Schizoaffective Disorder

TypeobservationalSponsorElazığ Mental Health and Diseases HospitalRan2025 to 2025Enrolled93ConditionsSchizoaffective Disorder
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Genome-wide association study of circulating vitamin D-binding protein.The American journal of clinical nutrition · 2014
    Trial
  5. Trial
  6. Vitamin D-binding protein haplotype is associated with hospitalization for RSV bronchiolitis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2014
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Suneil MalikOffice of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada.
Lei Fu
David James Juras
Mohamed Karmali
Betty Y L Wong
Agnes Gozdzik
David E C Cole
Public Health Agency of Canada · CAHealth Sciences Centre · CASunnybrook Health Science Centre · CASunnybrook Research InstituteUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF. Two missense variants of the DBP gene - rs7041 encoding Asp432Glu and rs4588 encoding Thr436Lys - change the amino acid sequence and alter the protein function. They are common enough to generate population-wide constitutive differences in vitamin D status, based on assay of the serum metabolite, 25-hydroxyvitamin D (25OHD). Whether these variants also influence the role of vitamin D in an immunologic milieu is not known. However, the issue is relevant, given the immunomodulatory effects of DBP and the role of protracted innate immune-related inflammation in response to tissue injury or repeated infection. Indeed, DBP and vitamin D may jointly or independently contribute to a variety of adverse health outcomes unrelated to classical notions of their function in bone and mineral metabolism. This review summarizes the reports to date of associations between DBP variants, and various chronic and infectious diseases. The available information leads us to conclude that DBP variants are a significant and common genetic factor in some common disorders, and therefore, are worthy of closer attention. In view of the heightened interest in vitamin D as a public health target, well-designed studies that look simultaneously at vitamin D and its carrier in relation to genotypes and adverse health outcome should be encouraged.

Indexed as

Genetic Predisposition to DiseaseHealthDiseaseHumansImmunity, InnateMutationVitamin D-Binding ProteinVitamin D-Binding Protein

Identifiers

PMID23427793
PMCPMC3613945
OpenAlexW2086690571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.